Specifically, in liposarcoma ALT proved to be a strong prognostic discriminant of increased mortality [9], whereas in glioblastoma the presence of ALT was associated to a better patient survival [8], suggesting that the prognostic relevance of ALT presumably reflects the distinct set of genetic changes that are associated to the activation of ALT in a given tumor type. This evidence concerns the gene GPT and neoplasm.